NEWS & EVENTS

Latest news and upcoming events

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
01 Jul 2026

Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio

Upcoming events

  • Swiss Biotech Day 2026
    4 May - 5 May, 2026
    Zurich

    download

  • Goodwin’s European Summit: 2026 Emerging VC Leaders in Life Sciences
    20 -22 May, 2026
    Malta

    download

  • CFO Forum
    21 - 22 May, 2026
    Málaga

    download

  • BIOSPAIN
    29 September - 1 October, 2026
    Bilbao

    download
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares<
04 Sep 2025

Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Proceeds will support lorundrostat clinical development, manufacturing, pre-commercialization, and expansion in hypertension and related diseases
VarmX receives FDA Fast Track Designation for lead asset VMX-C001<
03 Sep 2025

VarmX receives FDA Fast Track Designation for lead asset VMX-C001

Fast Track status aims to expedite review of drugs addressing serious conditions and unmet medical needs
Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock<
02 Sep 2025

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

Mineralys intends to use the net proceeds from the proposed offering to fund clinical development of lorundrostat
Leriglitazone Marketing Authorization Application submitted for treatment of cerebral adrenoleukodystrophy has been validated by European Medicines Agency<
23 Jul 2025

Leriglitazone Marketing Authorization Application submitted for treatment of cerebral adrenoleukodystrophy has been validated by European Medicines Agency

EMA has now validated the MAA file and it is under review by the Committee for Medicinal Products for Human Use (CHMP).
Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation<
23 Jul 2025

Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation

Novel antibody, potravitug, demonstrates high neutralization of all BKPyV serotypes with potential to transform treatment for kidney transplant recipients with BKPyV infection
Xeltis announces positive data for Xabg, its coronary artery bypass conduit, in EU clinical trial<
17 Jul 2025

Xeltis announces positive data for Xabg, its coronary artery bypass conduit, in EU clinical trial

Preliminary clinical data from Xabg, Xeltis' coronary artery bypass conduit (CABG), demonstrating positive safety and patency
Minoryx receives a EUR 26.9m grant within the framework of the European IPCEI Med4Cure project for the continued development of leriglitazone in lethal orphan CNS diseases<
17 Jul 2025

Minoryx receives a EUR 26.9m grant within the framework of the European IPCEI Med4Cure project for the continued development of leriglitazone in lethal orphan CNS diseases

The grant was given as part of the pan-European project “Important Project of Common European Interest (‘IPCEI') Med4Cure”
Top Spanish hospitals adopt the MAF Test to improve breast cancer treatment<
17 Jul 2025

Top Spanish hospitals adopt the MAF Test to improve breast cancer treatment

The MAF Test® could benefit more than 30,000 patients per year.
Topflight Pharma Development Veteran Joins Synendos<
15 Jul 2025

Topflight Pharma Development Veteran Joins Synendos

This appointment is particularly timely as the company moves towards Phase 2 clinical development of its lead drug asset SYT-510.
Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy<
11 Jul 2025

Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy

New peer-reviewed study published in Neuron

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.